Table 2 Baseline patient characteristics
n | % | |
|---|---|---|
Sex | ||
Male | 14 | 54 |
Female | 12 | 46 |
Age/years | ||
Median (range) | 50 (27–63) | |
Time from diagnosis of melanoma to brain metastases/(months) | ||
Median (range) | 36 (1–252) | |
Time from diagnosis of brain metastases to trial entry/(months) | ||
Median (range) | 1 (1–8) | |
Prior therapies | ||
Adjuvant immunotherapy | 7 | 27 |
Radiosurgery | 1 | 4 |
Resection of brain metastasis | 1 | 4 |
None | 17 | 65 |
Performance status | ||
Median (range) | 1 (0–2) | |
